Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of new pyrimido[5,4-c]quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies
Ramadan Ahmed Mekheimer, Samar M R Allam, Mariam A. Al‐Sheikh, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105693-105693
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 10
Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 9
Design, synthesis, and apoptotic antiproliferative action of new benzimidazole/1,2,3-triazole hybrids as EGFR inhibitors
Abubakar Ahmed, Anber F. Mohammed, Zainab M. Almarhoon, et al.
Frontiers in Chemistry (2025) Vol. 12
Open Access
Identification of a novel Src inhibitor K882 derived from quinazoline-based stilbenes with anti-NSCLC effect
Xiuwei Ma, Zongchen Ma, Xin Qi, et al.
Bioorganic Chemistry (2025), pp. 108185-108185
Closed Access
Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 376-386
Open Access | Times Cited: 27
Discovery of new Schiff bases of the disalicylic acid scaffold as DNA gyrase and topoisomerase IV inhibitors endowed with antibacterial properties
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Hayat Ali Alzahrani, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 5
Quinoline: A versatile bioactive scaffold and its molecular hybridization
Ibrahim A. Bala, Ohoud F. Al Sharif, Abdullah M. Asiri, et al.
Results in Chemistry (2024) Vol. 7, pp. 101529-101529
Open Access | Times Cited: 4
Microwave-assisted multicomponent synthesis of antiproliferative 2,4-dimethoxy-tetrahydropyrimido[4,5-b]quinolin-6(7H)-ones
Subham G. Patel, Aday González‐Bakker, Ruturajsinh M. Vala, et al.
RSC Advances (2022) Vol. 12, Iss. 47, pp. 30404-30415
Open Access | Times Cited: 25
Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
Lamya H. Al-Wahaibi, Yaser A. Mostafa, Mostafa Abdelrahman, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1006-1006
Open Access | Times Cited: 22
A comprehensive review of recent advances in the biological activities of quinazolines
Hesham A. M. Gomaa
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 639-655
Closed Access | Times Cited: 18
Design, synthesis and antimicrobial activity of novel quinoline-2-one hybrids as promising DNA gyrase and topoisomerase IV inhibitors
Mohammed A. I. Elbastawesy, Fatma A. Mohamed, Islam Zaki, et al.
Journal of Molecular Structure (2023) Vol. 1278, pp. 134902-134902
Closed Access | Times Cited: 10
Design, synthesis, molecular dynamics simulation, MM/GBSA studies and kinesin spindle protein inhibitory evaluation of some 4-aminoquinoline hybrids
Shriram D. Ranade, Shankar G. Alegaon, Venkatasubramanian Ulaganathan, et al.
Computational Biology and Chemistry (2023) Vol. 105, pp. 107881-107881
Closed Access | Times Cited: 10
Design, Synthesis, and Anti-Proliferative Action of Purine/Pteridine-Based Derivatives as Dual Inhibitors of EGFR and BRAFV600E
Samar El‐Kalyoubi, Hesham A. M. Gomaa, Elshimaa M. N. Abdelhafez, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 716-716
Open Access | Times Cited: 10
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties
Hesham A. Abou‐Zied, Eman A. M. Beshr, Hesham A. M. Gomaa, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 15
Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3- (2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFR WT/ EGFR T790M inhibitors
Lamya H. Al-Wahaibi, Anber F. Mohammed, Fatema El-Zahraa S. Abdel Rahman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 8
New series of 4,6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors
Yaser A. Mostafa, Abdeljalil Assoud, Ahmed Desoky, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
Novel indazole derivatives as potent apoptotic antiproliferative agents by multi-targeted mechanism: Synthesis and biological evaluation
Firas Obaid Arhema Frejat, Hongjin Zhai, Yaquan Cao, et al.
Bioorganic Chemistry (2022) Vol. 126, pp. 105922-105922
Closed Access | Times Cited: 12
Synthesis, Antioxidant and Antiproliferative Actions of 4-(1,2,3-Triazol-1-yl)quinolin-2(1H)-ones as Multi-Target Inhibitors
Essmat M. El‐Sheref, Stefan Bräse, Hendawy N. Tawfeek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13300-13300
Open Access | Times Cited: 6
Design, synthesis, and modelling study of new 1,2,3‐triazole/chalcone hybrids with antiproliferative action as epidermal growth factor receptor inhibitors
Mohamed T.‐E. Maghraby, Ola I. A. Salem, Bahaa G. M. Youssif, et al.
Chemical Biology & Drug Design (2022) Vol. 101, Iss. 3, pp. 749-759
Closed Access | Times Cited: 9
Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action
Fatma A. Mohamed, Saleha Y. M. Alakilli, Eman Fawzy El Azab, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 4, pp. 734-744
Closed Access | Times Cited: 5
Design and synthesis of new quinoline-ester/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
Aliaa M. Mohassab, Heba A. Hassan, Hesham A. Abou‐Zied, et al.
Journal of Molecular Structure (2023) Vol. 1297, pp. 136953-136953
Closed Access | Times Cited: 5
Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Two-step tandem synthesis of sugar-containing pyrimidine derivatives catalyzed by Lipozyme® TL IM in continuous-flow microreactors
Han-Jia Xie, Wen-Xuan Shao, Li‐Hua Du, et al.
RSC Advances (2024) Vol. 14, Iss. 51, pp. 38193-38199
Open Access | Times Cited: 1
Overview of the New Bioactive Heterocycles as Targeting Topoisomerase Inhibitors Useful Against Colon Cancer
Mirelly Barbosa Santos, Misael de Azevedo Teotônio Cavalcanti, Yvnni Maria Sales de Medeiros e Silva, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 24, Iss. 4, pp. 236-262
Closed Access | Times Cited: 4
Design, Synthesis, and Cytotoxic Activities of Indole and Indazole‐Based Stilbenes
Zongchen Ma, Wenjie Zhang, Xiao Han, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 5
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top